This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?
This week, we tag along with NephMadness. It will be hard to stay impartial while discussing the role of angiogenic and antiangiogenic factors in severe preeclampsia prognosis.
This week, during kidney month and NephMadness season, we will discuss the USRDS report as well as the ISN Global Kidney Health Atlas report from 2024.
We will be discussing a systematic review on treatment options for uremic pruritis. Such a simple symptom can be so bothersome, and is so common. Join us as we discuss the options on Sep 27
The chats were quite something. We sprinted through a lot of tweets in one hour each. Authors Chirag Parikh and Sherry Mansour joined us for first chat, and Sherry returned for the second chat too! Storifies below curated by Hector and Ben.
Could running marathons be hard on your kidneys, or at least biomarkers that track kidney injury> this paper in AJKD seems to suggest so. Join us to discuss this intriguing data and whether it should impact on runners, on May 23 and 24th.
One of the central problems with transplant is making sure patients take their anti-rejection medications. Reese et al. trialed a smart pill bottle that reminds patients to take their Program and snitches if they don't.